Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Chieko Makino‐Okamura
Observed name:
Chieko Makino-Okamura
Institution:
Kansai Medical University
Observed institutions:
Kansai Medical University,
Inserm,
RIKEN Center for Integrative Medical Sciences,
Institut de Biologie Moléculaire et Cellulaire,
Biosignal Research Center, Kobe University,
Kobe University
show all 6
ORCID:
0000-0001-7074-1494
Observed ORCID:
0000-0001-7074-1494
OpenAlex ID:
A5022504627
Works
12
Awards
1
Emergence of immunoregulatory Ym1 + Ly6C hi monocytes during recovery phase of tissue injury
2018
·
Naoki Ikeda
, Kenichi Asano
, et al.
·
Science Immunology
·
100
Landscape of protein–protein interactions in Drosophila immune deficiency signaling during bacterial challenge
2013
·
Hidehiro Fukuyama
, Yann Verdier
, et al.
·
Proceedings of the National Academy of Sciences
·
54
Requirement for memory B-cell activation in protection from heterologous influenza virus reinfection
2019
·
Sarah Leach
, Ryo Shinnakasu
, et al.
·
International Immunology
·
50
Frontline Science: Conversion of neutrophils into atypical Ly6G+SiglecF+ immune cells with neurosupportive potential in olfactory neuroepithelium
2020
·
Kei Ogawa
, Kenichi Asano
, et al.
·
Journal of Leukocyte Biology
·
26
Heparin inhibits melanosome uptake and inflammatory response coupled with phagocytosis through blocking PI3k/Akt and MEK/ERK signaling pathways in human epidermal keratinocytes
2014
·
Chieko Makino‐Okamura
, Yoko Niki
, et al.
·
Pigment Cell & Melanoma Research
·
23
S-Palmitoylation of Tyrosinase at Cysteine500 Regulates Melanogenesis
2022
·
Yoko Niki
, Naoko Adachi
, et al.
·
Journal of Investigative Dermatology
·
22
PDF
Potent SARS-CoV-2 neutralizing antibodies with therapeutic effects in two animal models
2022
·
Masaru Takeshita
, Hidehiro Fukuyama
, et al.
·
iScience
·
13
Repurposing the psoriasis drug Oxarol to an ointment adjuvant for the influenza vaccine
2020
·
Ryota Sato
, Chieko Makino-Okamura
, et al.
·
International Immunology
·
8
Diminished neutralizing activity against the XBB1.5 strain in 55.9% of individuals post 6 months COVID-19 mRNA booster vaccination: insights from a pseudovirus assay on 1,353 participants in the Fukushima vaccination community survey, Japan
2024
·
Tianchen Zhao
, Yuta Tani
, et al.
·
Frontiers in Immunology
·
3
PDF
Potent neutralizing broad-spectrum antibody against SARS-CoV-2 generated from dual-antigen-specific B cells from convalescents
2023
·
Masaru Takeshita
, Hidehiro Fukuyama
, et al.
·
iScience
·
3
PDF
TMPRSS2-induced Golgi disruption restricts the incorporation of virus envelope glycoproteins into virions
2026
·
Sayuri Seki
, Shigeyoshi Harada
, et al.
·
EMBO Reports
Receptor editing gatekeeps emergence of Influenza broadly neutralizing antibodies
2019
·
Fukuyama Hidehiro
, Chieko Makino‐Okamura
, et al.
·
日本免疫学会総会・学術集会記録(CD-ROM)
Show more works
View as search
Works count:
12
Citation count:
302
H-index:
8
I10-index:
7
Year
Topic
Type